• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国一家大型多医院机构 2004 年至 2012 年 9 年时间产碳青霉烯酶肠杆菌科细菌的长期控制:一项经验

Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.

机构信息

Infection Control Team, Direction de la Politique Medicale, Assistance Publique-Hopitaux de Paris, Paris, France.

出版信息

Euro Surveill. 2014 May 15;19(19):20802. doi: 10.2807/1560-7917.es2014.19.19.20802.

DOI:10.2807/1560-7917.es2014.19.19.20802
PMID:24852956
Abstract

In 2009, following the occurrence of several outbreaks of carbapenemase-producing Enterobacteriaceae (CPE), a programme for controlling the spread of CPE was implemented in the 38 hospitals of the Assistance Publique-Hôpitaux de Paris, a 21,000-bed institution. This programme included recommendations to isolate, and screen for CPE, patients previously hospitalised abroad, and bundled measures to control cross transmission (barrier precautions, dedicated staff and screening of contact patients). From 2004 to 2012, 140 CPE index cases were identified, 17 leading to outbreaks. After application of the programme, in spite of an increase in the number of CPE index cases epidemiologically linked with a recent stay or hospitalisation abroad, the proportion of cases followed by outbreaks, which was 40% (4/10) before 2009, decreased to 10% (13/130) (p=0.02), and the proportion of secondary cases among all CPE cases decreased from 69% (22/32) to 23% (38/168), (p<0.001). The number of secondary cases varied significantly depending on the speed and strength of the measures implemented around the CPE index case: quick (within two days of patient admission at the hospital) setting of nursing staff dedicated to the patient, quick setting of simple barrier precautions, or delayed measures of control (p=0.001). A sustained and coordinated strategy can lead to control CPE at the level of a large regional multi-hospital institution in a country where CPE are at an emerging stage.

摘要

2009 年,在几起因碳青霉烯酶产生肠杆菌科(CPE)爆发后,巴黎公立医院集团(AP-HP)的 38 家医院实施了一项控制 CPE 传播的计划,该机构有 21000 张床位。该计划包括对先前在国外住院的患者进行隔离和 CPE 筛查的建议,并采取综合措施控制交叉传播(屏障预防措施、专用人员和接触患者筛查)。2004 年至 2012 年,共发现 140 例 CPE 索引病例,其中 17 例导致爆发。该计划实施后,尽管与近期在国外逗留或住院相关的 CPE 索引病例数量有所增加,但随后爆发的病例比例从 2009 年前的 40%(4/10)下降到 10%(13/130)(p=0.02),CPE 病例中继发病例的比例从 69%(22/32)下降到 23%(38/168)(p<0.001)。继发病例的数量因围绕 CPE 索引病例实施措施的速度和力度而有显著差异:迅速(患者在医院入院后两天内)为患者分配专用护理人员,迅速设置简单的屏障预防措施,或延迟控制措施(p=0.001)。在一个新兴的 CPE 国家,持续和协调的策略可以在大型区域性多医院机构层面控制 CPE。

相似文献

1
Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.法国一家大型多医院机构 2004 年至 2012 年 9 年时间产碳青霉烯酶肠杆菌科细菌的长期控制:一项经验
Euro Surveill. 2014 May 15;19(19):20802. doi: 10.2807/1560-7917.es2014.19.19.20802.
2
Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.产碳青霉烯酶肠杆菌携带与跨境交流之间的关联:在一家大型法国多医院机构进行的为期八年的监测。
J Travel Med. 2012 Sep-Oct;19(5):320-3. doi: 10.1111/j.1708-8305.2012.00641.x. Epub 2012 Aug 1.
3
Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015.不同控制措施预防产碳青霉烯酶肠杆菌科和耐糖肽肠球菌爆发的效率:2010 年 1 月至 2015 年 12 月法国多医院机构的一项 6 年前瞻性研究。
Euro Surveill. 2018 Feb;23(8). doi: 10.2807/1560-7917.ES.2018.23.8.17-00078.
4
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.在一家大型多医院机构的规模上实现万古霉素耐药粪肠球菌的长期控制:七年经验。
Euro Surveill. 2012 Jul 26;17(30):20229.
5
Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.医疗体系不同层面产碳青霉烯酶肠杆菌科细菌的控制策略
Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:61-6. doi: 10.1016/S0213-005X(14)70176-4.
6
Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.集束化防控策略是控制产碳青霉烯酶肠杆菌科爆发的唯一方法吗?一项单中心经验。
J Hosp Infect. 2018 Aug;99(4):390-395. doi: 10.1016/j.jhin.2018.02.003. Epub 2018 Feb 10.
7
Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.急性环境中碳青霉烯酶肠杆菌科爆发的控制:证据回顾。
J Hosp Infect. 2017 Jan;95(1):3-45. doi: 10.1016/j.jhin.2016.10.006. Epub 2016 Oct 14.
8
Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.运用美国疾病控制与预防中心2012年耐碳青霉烯类肠杆菌科细菌工具包中所倡导的干预措施,控制重症监护病房内产碳青霉烯酶肠杆菌科细菌和广泛耐药鲍曼不动杆菌感染的同时暴发。
Infect Control Hosp Epidemiol. 2014 Jul;35(7):810-7. doi: 10.1086/676857. Epub 2014 May 15.
9
Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.养老机构产碳青霉烯酶肠杆菌科的控制策略:基于三起暴发的启示。
J Hosp Infect. 2019 Feb;101(2):183-187. doi: 10.1016/j.jhin.2018.10.020. Epub 2018 Oct 30.
10
Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.2007年至2014年挪威产碳青霉烯酶肠杆菌科细菌的分子及流行病学特征
PLoS One. 2017 Nov 15;12(11):e0187832. doi: 10.1371/journal.pone.0187832. eCollection 2017.

引用本文的文献

1
Evaluation of the Xpert Carba-R assay for quantifying carbapenemase-producing bacterial load in stool samples.评估 Xpert Carba-R 检测法用于定量粪便样本中产碳青霉烯酶细菌负荷量。
PLoS One. 2024 Aug 28;19(8):e0309089. doi: 10.1371/journal.pone.0309089. eCollection 2024.
2
Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study.控制医院中产碳青霉烯酶肠杆菌科传播的策略的成本效益:建模研究。
Antimicrob Resist Infect Control. 2022 Sep 19;11(1):117. doi: 10.1186/s13756-022-01149-0.
3
Rectal and Tracheal Carriage of Carbapenemase Genes and Class 1 and 2 Integrons in Patients in Neurosurgery Intensive Care Unit.
神经外科重症监护病房患者中碳青霉烯酶基因以及1类和2类整合子在直肠和气管中的携带情况
Antibiotics (Basel). 2022 Jul 3;11(7):886. doi: 10.3390/antibiotics11070886.
4
Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China.中国某地区产碳青霉烯酶肠杆菌科细菌的克隆传播。
BMC Microbiol. 2022 Mar 29;22(1):81. doi: 10.1186/s12866-022-02497-y.
5
Comparison of the Clinical Outcomes of Patients With Positive Xpert Carba-R Tests for Carbapenemase-Producing Enterobacterales According to Culture Positivity.根据培养结果对碳青霉烯酶产生肠杆菌科细菌Xpert Carba-R检测呈阳性患者的临床结局进行比较。
Open Forum Infect Dis. 2022 Jan 10;9(1):ofab594. doi: 10.1093/ofid/ofab594. eCollection 2022 Jan.
6
Neonates with Maternal Colonization of Carbapenemase-Producing, Carbapenem-Resistant Enterobacteriaceae: A Mini-Review and a Suggested Guide for Preventing Neonatal Infection.产碳青霉烯酶、耐碳青霉烯肠杆菌科细菌母婴定植的新生儿:综述及预防新生儿感染的建议指南
Children (Basel). 2021 May 15;8(5):399. doi: 10.3390/children8050399.
7
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.某大学医院 ICU 和 HSCT 病房高危患者中产碳青霉烯酶肠杆菌科直肠定植的流行病学和危险因素。
Antimicrob Resist Infect Control. 2020 Sep 23;9(1):155. doi: 10.1186/s13756-020-00816-4.
8
Epidemiological and Microbiome Associations Between and Vancomycin-Resistant Colonization in Intensive Care Unit Patients.重症监护病房患者中[具体内容缺失]与耐万古霉素[具体内容缺失]定植之间的流行病学和微生物组关联
Open Forum Infect Dis. 2020 Jan 12;7(1):ofaa012. doi: 10.1093/ofid/ofaa012. eCollection 2020 Jan.
9
Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015.不同控制措施预防产碳青霉烯酶肠杆菌科和耐糖肽肠球菌爆发的效率:2010 年 1 月至 2015 年 12 月法国多医院机构的一项 6 年前瞻性研究。
Euro Surveill. 2018 Feb;23(8). doi: 10.2807/1560-7917.ES.2018.23.8.17-00078.
10
A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.碳青霉烯类耐药肠杆菌科的临床流行病学系统评价和荟萃分析。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01730-17. Print 2018 Jan.